India’s apex drug regulator has reported findings of spurious versions of five critical drugs being sold in the market.The regulator also declared 50 other medicines as “not of standard quality”
India’s apex drug regulator has reported findings of spurious versions of five critical drugs being sold in the market.The regulator also declared 50 other medicines as “not of standard quality”